Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Niagen Bioscience Inc (NASDAQ: NAGE) closed at $10.10 in the last session, up 3.80% from day before closing price of $9.73. In other words, the price has increased by $3.80 from its previous closing price. On the day, 1.04 million shares were traded. NAGE stock price reached its highest trading level at $10.185 during the session, while it also had its lowest trading level at $9.845.
Ratios:
We take a closer look at NAGE’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.80. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On August 11, 2022, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $2.40.
On March 08, 2022, ROTH Capital started tracking the stock assigning a Buy rating and target price of $7.ROTH Capital initiated its Buy rating on March 08, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAGE now has a Market Capitalization of 795573952 and an Enterprise Value of 745320256. As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 58.48, and their Forward P/E ratio for the next fiscal year is 43.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.37 while its Price-to-Book (P/B) ratio in mrq is 14.31. Its current Enterprise Value per Revenue stands at 6.906 whereas that against EBITDA is 53.154.
Stock Price History:
The Beta on a monthly basis for NAGE is 2.03, which has changed by 1.9022989 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, NAGE has reached a high of $10.00, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is 34.95%, while the 200-Day Moving Average is calculated to be 83.01%.
Shares Statistics:
According to the various share statistics, NAGE traded on average about 1.07M shares per day over the past 3-months and 1367680 shares per day over the past 10 days. A total of 78.43M shares are outstanding, with a floating share count of 49.74M. Insiders hold about 36.86% of the company’s shares, while institutions hold 30.13% stake in the company. Shares short for NAGE as of 1745971200 were 2461532 with a Short Ratio of 2.29, compared to 1743379200 on 1748105. Therefore, it implies a Short% of Shares Outstanding of 2461532 and a Short% of Float of 4.77.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
